BIOTYPE launches Modaplex landing page
February 13,


Dresden-Hellerau, February 13th 2019. Our cooperation partner BIOTYPE is expanding its product portfolio by offering assays and services for the Modaplex, a novel molecular diagnostic platform that bridges the gap between qPCR and Next Generation ...

First CE-IVD certified Modaplex assay launched
November 2,


Dresden-Hellerau, 02 November 2018. After launching two assays for MSI and POLE/POLD1 analysis this year, Biotype Innovation introduces its first CE-IVD certified test kit running on the Modaplex system. The Modaplex Clostridium difficile Analysis Kit ...

Biotype extends biomarker detection portfolio with the Modaplex POLE/POLD1 Mutation Analysis Kit
July 26,


The Modaplex POLE/POLD1 mutation detection complements MSI testing to facilitate the decision-making on the appropriate immune checkpoint inhibitor (ICI) therapy Dresden-Hellerau, 26 July 2018. Therapy with immune checkpoint inhibitors has the potential ...

Microsatellite instabillity (MSI) detection in less than 5 hours
May 18,


Biotype Innovation presents new Modaplex MSI Analysis Kit at DGP congress in Berlin Dresden-Hellerau, 18 May 2018. Meet Biotype Innovation at the German Society of Pathology (DGP) congress in Berlin. The 102nd Annual Meeting of the DGP will take place ...

MSI Analysis Kit launched by Biotype Innovation
May 17,


Contributing to informed decisions on immune checkpoint therapies Dresden-Hellerau, 17 May 2018. With the Modaplex MSI Analysis Kit, Biotype Innovation introduces its next product into the market. The MSI (microsatellite instability) kit is the first ...

From Idea to IVD – Contract development & manufacturing of in-vitro diagnostics
March 26,


Biotype Innovation’s contract development service for molecular diagnostic innovations is expanding. Since our inauguration in April 2015, we offer integrated solutions that are customized to your requirements, including development, manufacture, and ...

June 19,


Dresden-Hellerau, June 19, 2017. Just two years after its foundation and a year after the lab inauguration, Biotype Innovation successfully launches its first four products. The company developed a unique FGFR panel (fibroblast growth factor receptor) ...

March 30,


Hellerau, March 30th 2017. Biotype Innovation GmbH is set to present its latest technology at the upcoming 8th international Gene Quantification Event in Freising, Germany, close to Munich. From April 3–7, 2017, the qPCR, dPCR & NGS Event will bring ...

March 2,


Dresden-Hellerau, 2nd March 2017. On Wednesday 22nd February 2017, the Sächsische Zeitung online published an article about the Dresden company association Molecular Diagnostics Group (MDG) and one of its founders, Dr. Wilhelm Zörgiebel. The article, ...

February 9,


Dresden-Hellerau, 9th February 2017. On Monday 6th February 2017, Barbara Klepsch, Saxony’s State Minister of Health, payed a visit to the Dresden company association Molecular Diagnostics Group (MDG). During her tour around the offices in ...